Search Results - "Ahmed, Sherihan Rezk"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial by Zeinhom, Mohamed G., Khalil, Mohamed Fouad Elsayed, Kamel, Islam Fathallah Mohamed, Kohail, Ahmed Mohamed, Ahmed, Sherihan Rezk, Elbassiouny, Ahmed, Shuaib, Ashfaq, Al-Nozha, Omar M

    Published in Scientific reports (12-03-2024)
    “…Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in…”
    Get full text
    Journal Article
  2. 2

    Evaluation of dysphagia in different phenotypes of early and idiopathic Parkinsonism by Mohamed, Al-Amir Bassiouny, Mohamed, Gharib Fawi, Elnady, Hassan Mohamed, Sayed, Mohamed Abdelmoneim, Imam, Ahmed Mamdouh, Hassan, Megahed Mohamed, Ahmed, Sherihan Rezk

    “…Parkinsonism (PD) is a common neurodegenerative disorders into which dysphagia occurs mainly in the late stage and to a lesser extent in an early stage…”
    Get full text
    Journal Article
  3. 3

    Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial by Zeinhom, Mohamed G., Elbassiouny, Ahmed, Mohamed, Ahmed Mahmoud, Ahmed, Sherihan Rezk

    Published in CNS drugs (01-05-2024)
    “…Background Large-vessel ischemic stroke represents about 25–40% of all ischemic strokes. Few clinical trials compared ticagrelor versus clopidogrel in ischemic…”
    Get full text
    Journal Article
  4. 4

    Association of white matter hyperintensities with migraine phenotypes and response to treatment by Ahmed, Sherihan Rezk, Mohamed, Amr Abdel Monem, Salem, Haitham Hamdy, Helmy, Shahinaz, Moustafa, Ramez Reda, Borham, Sherien Mohamed Farag

    Published in Acta neurologica Belgica (01-10-2023)
    “…Introduction White matter hyperintensities (WMHs) are frequently found in migraineurs. However, their clinical significance and correlation to different…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a randomized, controlled trial by Elgamal, Shimaa, Ahmed, Sherihan Rezk, Nahas, Mohamed M., Hendawy, Shimaa R., Elshafei, Osama, Zeinhom, Mohamed G.

    Published in Acta neurologica Belgica (01-06-2024)
    “…Background Migraine affects 11–15% of people worldwide, and the calcitonin gene-related peptide (CGRP) is released during the migraine attack, producing…”
    Get full text
    Journal Article